Gianluigi Reda

18PUBLICATIONS
102CO-AUTHORS
Haematological tumoursGene and molecular therapyCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 29, 2023
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò

|Jun 09, 2023
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS).

Esther Natalie Oliva, Marta Riva, Pasquale Niscola

|Nov 02, 2021
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò

|Mar 25, 2021
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes.

Guillermo Garcia-Manero, Valeria Santini, Antonio Almeida

|Jun 13, 2018
Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study.

Gianluigi Reda, Bruno Fattizzo, Ramona Cassin

Pageof 3

Frequent Collaborators

10 joint publications

Francesca Romana Mauro

10 joint publications

Luca Laurenti

9 joint publications

Andrea Visentin

5 joint publications

Massimo Gentile